Rhythm Pharmaceuticals Alström Syndrome setmelanotide
Rhythm enrols first patient in Phase lll trial of setmelanotide
Rhythm Pharmaceuticals has enrolled the first patient in a pivotal Phase lll clinical trial examining setmelanotide for the treatment of…
